NCT02736695 Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia Status COMPLETED Phase PHASE1
NCT02730819 Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma Status COMPLETED Phase PHASE2
NCT02730546 Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT02728726 Sugammadex vs Placebo to Prevent Residual Neuromuscular Block Status COMPLETED Phase PHASE4
NCT02726282 Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences: a Cross Sectional Survey Status WITHDRAWN Phase N/A
NCT02722707 Clinical Use of a Magnetic Anal Sphincter Augmentation Device, Trade Name FENIX Status NO_LONGER_AVAILABLE Phase N/A
NCT02722434 MC5-A Scrambler Therapy or TENS Therapy in Treating Patients With Chemotherapy-Induced Peripheral Neuropathy Status COMPLETED Phase NA
NCT02721537 Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes Status COMPLETED Phase NA
NCT02718742 Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder Cancer Status WITHDRAWN Phase PHASE2
NCT02714660 The Work of Being a Patient With Diabetes: Data Collection Via a Smartphone Application Status COMPLETED Phase N/A
NCT02713516 Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and OCD Status COMPLETED Phase NA
NCT02713425 Pediatric Anxiety Intervention With an Entertaining Video Game: Feasibility Study Status COMPLETED Phase NA
NCT02705638 Treatment of IgG4-Related Disease With Revlimid and Rituximab Status COMPLETED Phase PHASE1
NCT02705404 A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing Status TERMINATED Phase N/A
NCT02705053 At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation Status COMPLETED Phase PHASE3